Biophotonics Market worth $63.1 Billion by 2022

The global market size is estimated to reach $63.1 billion by 2022 from $31.6 billion in 2015, growing at a CAGR of 10.4% from 2016 to 2022. In 2015, North America dominated with over 37% share of the overall market, and is anticipated to continue this trend during the forecast period.

Biophotonics is a technology used to produce and harness light to visualize, detect, and manipulate biological materials. The global biophotonics market is driven by emergence of nanotechnology, development in biosensors, and availability of funds for R&D. However, high price of biophotonics-based instruments due to complexity of this technology restrains the growth of the market.

Request Sample Copy@ https://www.alliedmarketresearch.com/request-sample/1531

In 2015, medical diagnostics held over 68% market share, in terms of revenue. Technological advancements in the field of diagnostics, rise in incidences of chronic diseases, and increase in healthcare awareness are the key factors that contribute to the growth of the biophotonics market. Moreover, owing to increase in geriatric population, the role and importance of medical diagnostics are expanding, which considerably drives the market growth.

By application, the see-through imaging segment held over 28% of the revenue share in 2015, owing to increase in research in this field. North America dominated the global biophotonics market with over 36% share in overall revenue, and is anticipated to grow at the CAGR of 9.5%, followed by Europe, Asia-Pacific, and LAMEA.

Purchase Inquiry@ https://www.alliedmarketresearch.com/purchase-enquiry/1531

Dominating Market Players Profiled in this Industry Insight:

•Affymetrix Inc.
•Andor Technology Ltd.
•Carl Zeiss AG
•Becton, Dickinson and Company
•FEI Company
•Hamamatsu Photonics K.K.
•Lumenis Ltd., Olympus Corporation
•PerkinElmer Inc.
•Zecotek Photonics Inc.

Biophotonics Market Key Findings:

•Medical diagnostics segment dominated the market in 2015, with over 68% of market share. However, nonmedical application segment is expected to grow at a higher CAGR of 14.3%.

•See-through imaging application segment accounted for about 28% of the market in 2015.

•LAMEA is anticipated to show high growth rate owing to the rapidly growing automotive industry.

•Asia-Pacific dominated the market in 2015 due surge in demand for biophotonics-based devices in China, South Korea, and Japan.

Connect to Analyst@ https://www.alliedmarketresearch.com/connect-to-analyst/1531

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.